Oasis Health Products, Inc. Announces Completion Of Stability Testing On Itonis, Inc.'s EMESYL™ Nausea Relief

Posted 03:20:00 12/17/2014 by Admin


LAS VEGAS, Dec. 17, 2014 /PRNewswire/ -- Oasis Health Products, Inc. announced today the completion of stability testing on Itonis, Inc.'s EMESYL™ Nausea Relief product and its scheduled release on December 19, 2014.

Oasis Health Products, a wholly owned subsidiary of Migranade, Inc. has confirmed that it has completed stability testing on EMESYL™ Nausea Relief giving the product an initial shelf life of 2 years.

"Now that the stability tests have been completed, we have scheduled a December 19th release date for the product," said Darren Krein, Oasis's Chief Executive Officer. "We are excited about EMESYL™ Nausea Relief as we expect it to be a big profit center for the company going forward."

ABOUT OASIS HEALTH PRODUCTS, INC.
Oasis Health Products, an FDA inspected, GMP facility, is one of the few manufacturers capable of producing high quality homeopathic medicines. Oasis provides formula & product development and manufacturing, advice, guidance, and contacts in areas such as sales, distribution, logistics, marketing, warehousing, etc.

For media inquiries contact Orange County, CA Public Relations Agency www.drivenpublicrelations.com or send an email to info@oasishp.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/oasis-health-products-inc-announces-completion-of-stability-testing-on-itonis-incs-emesyl-nausea-relief-300011565.html

SOURCE Oasis Health Products, Inc.



 

Stock Quote - ITNS

ITNS Last:  $0.0016 Change:  -0.0001

Investor Relations

Itonis Holdings Company is a trade name of Itonis Inc. (OTC:ITNS), a publicly traded company.



Contact our office at (949) 200-8887 or email us at office@itonisholdings.com for more information.